Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 39110925.
- Also identified by DOI 10.1200/JCO.24.00709.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Our international team highlights issues with efficacy reports in several studies on DMG with the new drug ONC201.
Medical subject headings
- Neoplasms